CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Creatine Phosphate

磷酸肌酸 杂质对照品Creatine Phosphate Impurities

28 个杂质条目28 impurity entries

本页汇总 磷酸肌酸 的 28 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 28 impurity reference standards of Creatine Phosphate. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 磷酸肌酸(Creatine Phosphate)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesA stability-Indicating HPLC Method for Simultaneous Determination of Creatine Phosphate Sodium and its Related Substances in Pharmaceutical Formulation
    Iranian journal of pharmaceutical research : IJPR · 2016 · Xie Z et al.  ·  PMID 27610152
  2. 杂质研究Impurity studiesSimultaneous determination of myocardial nucleotides, nucleosides, purine bases and creatine phosphate by ion-pair high-performance liquid chromatography
    Journal of chromatography · 1992 · Fürst W, Hallström S  ·  PMID 1400784  ·  DOI
  3. 分析方法Analytical MethodsSpectrophotometric and chromatographic analysis of creatine:creatinine crystals in urine
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2024 · Werle J et al.  ·  PMID 38996762  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisSYNTHESIS OF CREATINE PHOSPHATE BY THE CRYSTALLINE LENS; IN NORMAL CONDITIONS AND DURING THE DEVELOPMENT OF GALACTOSE CATARACT
    American journal of ophthalmology · 1964 · COTLIER E  ·  PMID 14106903  ·  DOI
  • 合成方法SynthesisThe effects of magnesium ions and of creatine phosphate on the synthesis of acetylcholine
    The Journal of physiology · 1947 · FELDBERG W, HEBB C  ·  PMID 20241953

磷酸肌酸 —— 原料药与杂质对照品Creatine Phosphate — drug substance & impurities

共 28 个条目(含原料药本体)28 items incl. the drug substance
Creatine Phosphate structure
原料药 APIAPI
磷酸肌酸Creatine Phosphate
Creatine Phosphate
CAS No.67-07-2
Chemical FormulaC4H10N3O5P
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Disodium Tetrahydrate structure
—
磷酸肌酸二钠四水合物Creatine Phosphate Disodium Tetrahydrate
Creatine Phosphate Disodium Tetrahydrate
CAS No.71519-72-7
Chemical FormulaC4H8N3O5P2-·2Na+·4H2O
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Disodium structure
—
磷酸肌酸二钠Creatine Phosphate Disodium
Creatine Phosphate Disodium
CAS No.922-32-7
Chemical FormulaC4H8N3O5P2-·2Na+
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 5 structure
5
磷酸肌酸杂质5Creatine Phosphate Impurity 5
Creatine Phosphate Impurity 5
CAS No.512-56-1
Chemical FormulaC3H9O4P
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 9 structure
9
磷酸肌酸杂质9Creatine Phosphate Impurity 9
Creatine Phosphate Impurity 9
CAS No.2832257-94-8
Chemical FormulaC10H22N3O5P
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 12 structure
12
磷酸肌酸杂质12Creatine Phosphate Impurity 12
Creatine Phosphate Impurity 12
CAS No.616-04-6
Chemical FormulaC4H6N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 15 structure
15
磷酸肌酸杂质15Creatine Phosphate Impurity 15
Creatine Phosphate Impurity 15
CAS No.5616-32-0
Chemical FormulaC3H6N2
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 16 structure
16
磷酸肌酸杂质16Creatine Phosphate Impurity 16
Creatine Phosphate Impurity 16
CAS No.4316-73-8
Chemical FormulaC3H6NNaO2
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 17 Sulfate structure
17
磷酸肌酸杂质17 硫酸盐Creatine Phosphate Impurity 17 Sulfate
Creatine Phosphate Impurity 17 Sulfate
CAS No.202401-10-3
Chemical FormulaC2H7N3·H2SO4
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 17 structure
17
磷酸肌酸杂质17Creatine Phosphate Impurity 17
Creatine Phosphate Impurity 17
CAS No.21770-81-0
Chemical FormulaC2H7N3·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 17 Monomer structure
17
磷酸肌酸杂质17 单体Creatine Phosphate Impurity 17 Monomer
Creatine Phosphate Impurity 17 Monomer
CAS No.471-29-4
Chemical FormulaC2H7N3
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 18 structure
18
磷酸肌酸杂质18Creatine Phosphate Impurity 18
Creatine Phosphate Impurity 18
CAS No.71160-37-7
Chemical FormulaC5H7NNa2O4
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 19 structure
19
磷酸肌酸杂质19Creatine Phosphate Impurity 19
Creatine Phosphate Impurity 19
CAS No.1934-75-4
Chemical FormulaC2N3Na
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 21(Tetrabenzyl Diphosphate) structure
21
磷酸肌酸杂质21( 焦磷酸四苄酯)Creatine Phosphate Impurity 21(Tetrabenzyl Diphosphate)
Creatine Phosphate Impurity 21(Tetrabenzyl Diphosphate)
CAS No.990-91-0
Chemical FormulaC28H28O7P2
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 22 structure
22
磷酸肌酸杂质22Creatine Phosphate Impurity 22
Creatine Phosphate Impurity 22
CAS No.959586-66-4
Chemical FormulaC11H22N3O7P
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 23 structure
23
磷酸肌酸杂质23Creatine Phosphate Impurity 23
Creatine Phosphate Impurity 23
CAS No.168693-61-6
Chemical FormulaC5H10N3O5P
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 24 structure
24
磷酸肌酸杂质24Creatine Phosphate Impurity 24
Creatine Phosphate Impurity 24
CAS No.2416090-41-8
Chemical FormulaC6H14N3O5P
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 25 structure
25
磷酸肌酸杂质25Creatine Phosphate Impurity 25
Creatine Phosphate Impurity 25
CAS No.959586-52-8
Chemical FormulaC9H18N3O8P
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 26 structure
26
磷酸肌酸杂质26Creatine Phosphate Impurity 26
Creatine Phosphate Impurity 26
CAS No.959586-49-3
Chemical FormulaC9H18N3O7P
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 27 structure
27
磷酸肌酸杂质27Creatine Phosphate Impurity 27
Creatine Phosphate Impurity 27
CAS No.22620-95-7
Chemical FormulaNa3O3P
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 28 structure
28
磷酸肌酸杂质28Creatine Phosphate Impurity 28
Creatine Phosphate Impurity 28
CAS No.26993-30-6
Chemical FormulaC18H38NO5P
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 29 structure
29
磷酸肌酸杂质29Creatine Phosphate Impurity 29
Creatine Phosphate Impurity 29
CAS No.1241-94-7
Chemical FormulaC20H27O4P
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 30 structure
30
磷酸肌酸杂质30Creatine Phosphate Impurity 30
Creatine Phosphate Impurity 30
CAS No.98924-69-7
Chemical FormulaC18H22N3O5P
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 32 structure
32
磷酸肌酸杂质32Creatine Phosphate Impurity 32
Creatine Phosphate Impurity 32
CAS No.97904-31-9
Chemical FormulaC3N4
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 33 structure
33
磷酸肌酸杂质33Creatine Phosphate Impurity 33
Creatine Phosphate Impurity 33
CAS No.26292-51-3
Chemical FormulaC15H17O4P
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 34 structure
34
磷酸肌酸杂质34Creatine Phosphate Impurity 34
Creatine Phosphate Impurity 34
CAS No.39799-77-4
Chemical FormulaC4H6N2O
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 35 structure
35
磷酸肌酸杂质35Creatine Phosphate Impurity 35
Creatine Phosphate Impurity 35
CAS No.1569448-16-3
Chemical FormulaC3H6N2
Purity>95%询价On request
10mg25mg50mg100mg
Creatine Phosphate Impurity 36 structure
36
磷酸肌酸杂质36Creatine Phosphate Impurity 36
Creatine Phosphate Impurity 36
CAS No.928-54-1
Chemical FormulaC4H4N2
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

磷酸肌酸 —— 研究文献与合成路线Creatine Phosphate — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 磷酸肌酸 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Creatine Phosphate. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. A stability-Indicating HPLC Method for Simultaneous Determination of Creatine Phosphate Sodium and its Related Substances in Pharmaceutical Formulation
    Xie Z, Wei L, Yang Q, et al. · Iranian journal of pharmaceutical research : IJPR · 2016 · 被引 2cited 2

合成与制备工艺专利Synthesis & process patents

  1. Creatine phosphate sodium compound and method for synthesizing the same
    XIANFENG ZHENG · 公开号 CN101486730CN101486730 · 2009
  2. Creatine phosphate sodium microballoon lyophilized preparation and method for producing the same
    MIN QIU · 公开号 CN101474159CN101474159 · 2009
  3. Creatine phosphate sodium lipidosome freeze-dried preparation and preparation method thereof
    MING WANG · 公开号 CN101530391CN101530391 · 2009
  4. Creatine phosphate arginine salt and preparing method thereof
    CHEN WENZHAN WANG · 公开号 CN101012240CN101012240 · 2007
  5. Medicinal disodium creatine phosphate hexahydrate and preparing method thereof
    LU WEI ZHANG · 公开号 CN101033237CN101033237 · 2007

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

磷酸肌酸 杂质谱研究要点Creatine Phosphate — impurity profiling notes

下面这些是拿到 磷酸肌酸 的 28 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 28 impurity entries for Creatine Phosphate, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances